Veracyte Inc
NASDAQ:VCYT

Watchlist Manager
Veracyte Inc Logo
Veracyte Inc
NASDAQ:VCYT
Watchlist
Price: 43.84 USD -1.17% Market Closed
Market Cap: 3.5B USD

Wall Street
Price Targets

VCYT Price Targets Summary
Veracyte Inc

Wall Street analysts forecast VCYT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VCYT is 49.33 USD with a low forecast of 43.43 USD and a high forecast of 59.85 USD.

Lowest
Price Target
43.43 USD
1% Downside
Average
Price Target
49.33 USD
13% Upside
Highest
Price Target
59.85 USD
37% Upside
Veracyte Inc Competitors:
Price Targets
CNTB
Connect Biopharma Holdings Ltd
239% Upside
9926
Akeso Inc
50% Upside
251120
Bio-FD&C Co Ltd
18% Upside
REGN
Regeneron Pharmaceuticals Inc
15% Upside
300685
Amoy Diagnostics Co Ltd
34% Upside
ENTA
Enanta Pharmaceuticals Inc
32% Upside
2157
Lepu Biopharma Co Ltd
89% Upside
BCRX
BioCryst Pharmaceuticals Inc
176% Upside

Revenue
Forecast

Revenue Estimate
Veracyte Inc

For the last 12 years the compound annual growth rate for Veracyte Inc's revenue is 36%. The projected CAGR for the next 3 years is 13%.

36%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Veracyte Inc

The compound annual growth rate of Veracyte Inc's operating income for the next 3 years is 77%.

N/A
Past Growth
77%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
Veracyte Inc

The compound annual growth rate of Veracyte Inc's net income for the next 3 years is 59%.

N/A
Past Growth
59%
Estimated Growth
Estimates Accuracy
-43%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VCYT's stock price target?
Price Target
49.33 USD

According to Wall Street analysts, the average 1-year price target for VCYT is 49.33 USD with a low forecast of 43.43 USD and a high forecast of 59.85 USD.

What is Veracyte Inc's Revenue forecast?
Projected CAGR
13%

For the last 12 years the compound annual growth rate for Veracyte Inc's revenue is 36%. The projected CAGR for the next 3 years is 13%.

What is Veracyte Inc's Operating Income forecast?
Projected CAGR
77%

The compound annual growth rate of Veracyte Inc's operating income for the next 3 years is 77%.

What is Veracyte Inc's Net Income forecast?
Projected CAGR
59%

The compound annual growth rate of Veracyte Inc's net income for the next 3 years is 59%.

Back to Top